MedTrace Logo

Effect of Learning and Coping Strategies in Cardiac Rehabilitation - Group Study

NCT01668394 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 825

Last updated 2018-03-12

No results posted yet for this study

Summary

Background: It is well known that cardiac rehabilitation has potential to reduce morbidity and mortality, but not all patients complete CR. This LC-REHAB trial aims to compare the effect of a new patient education method called learning and coping strategies to that of standard care.

Design: Randomised controlled trial, 1:1 ratio. Participants: Patients above 18 years newly hospitalised with either ischaemic heart disease or heart failure.

Setting: Three hospital Units in Central Denmark Region. Intervention: Cardiac rehabilitation with addition of learning and coping strategies which include participation of experienced patients as co-educators, clarifuing interviews, and inductive teaching style.

Control arm: Standard care cardiac rehabilitation with a decuctive teaching style.

Outcomes: Adherence to cardiac rehabilitation, morbidity, mortality, risk factors, lifestyle, health related quality of life, return to work.

Conditions

  • Rehabilitation

Interventions

BEHAVIORAL

Learning and coping arm

Participation of experienced patients as co-educators. Completion of two individual clarifying interviews. Teaching style: situated, reflective, inductive.

OTHER

Control arm

Usual care. Teaching style: deductive.

Sponsors & Collaborators

  • Herning Hospital

    lead OTHER

Principal Investigators

  • Vibeke Lynggaard, MHsc · Regional Hospital West Jutland

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2016-05-31
Completion
2018-03-08

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01668394 on ClinicalTrials.gov